Interventions for treating pre-eclampsia and its consequences: Generic protocol

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Duley, Lelia ^a   Henderson Smart, David J ^b   Walker, Godfrey J A ^c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Queen Elizabeth II Research Institute for Mothers and Infants   (Australia)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; ASCORBIC ACID; CALCIUM; CORTICOSTEROID; DIAZEPAM; DIURETIC AGENT; DOPAMINE; MAGNESIUM; MAGNESIUM SULFATE; NITRIC OXIDE; PHENYTOIN; PROGESTERONE; SELENIUM; ZINC;

ADVERSE OUTCOME; BLINDNESS; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; BREAST FEEDING; CALORIC INTAKE; CAUSE OF DEATH; CEREBRAL PALSY; CESAREAN SECTION; CHILD DEVELOPMENT; CHILD GROWTH; CHILDHOOD MORTALITY; CLINICAL PROTOCOL; CLINICAL TRIAL; DIET SUPPLEMENTATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG SAFETY; ECLAMPSIA; ELECTIVE SURGERY; EMERGENCY SURGERY; EXERCISE; GARLIC; HEALTH CARE COST; HEARING IMPAIRMENT; HEART OUTPUT; HELLP SYNDROME; HEMOLYSIS; HUMAN; HYPERTENSION; INFECTION; KIDNEY FAILURE; LIFESTYLE MODIFICATION; LIVER FAILURE; LOW DRUG DOSE; LUNG EDEMA; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; MENTAL DEFICIENCY; META ANALYSIS; MOTHER CHILD RELATION; NECROTIZING ENTEROCOLITIS; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PRENATAL CARE; PROTEIN INTAKE; PUERPERAL DEPRESSION; RESPIRATORY DISTRESS SYNDROME; RETROLENTAL FIBROPLASIA; REVIEW; RISK ASSESSMENT; RISK FACTOR; SALT INTAKE; SEIZURE; SMALL FOR DATE INFANT; STILLBIRTH; STROKE; SYSTEMATIC REVIEW;

EID: 70349099270     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007756     Document Type: Review

References (70)

1. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD002252.pub2] (Pubitemid 351820393)
2. American College of Obstetricians and Gynecologists. Hypertension in Pregnancy. ACOG Technical Bulletin No 219. Vol. 219, Washington: ACOG, 1996:1-8.
3. The Albumin Reviewers, Alderson P, Bunn F, Li Wan Po A, Li L, et al.Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD001208.pub2]
4. Ananth CV, Savitz DA, Bowes WA Jr. Hypertensive disorders of pregnancy and stillbirth in North Carolina, 1988 to 1991. Acta Obstetricia et Gynecologica Scandinavica 1995;74(10):788-793
5. Anthony J. Improving antenatal care: the role of an antenatal assessment unit. Health Trends 1992;24(4):123-125
6. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335(7627):974. (Pubitemid 350144670)
7. Bergel E, Carroli G, Althabe F. Ambulatory versus conventional methods for monitoring blood pressure during pregnancy. Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI: DOI: 10.1002/14651858.CD001231]
8. Bouvier-Colle MH, Salanave B, Ancel PY, Varnoux N, Fernandez H, Papiernik E, et al.Obstetric patients treated in intensive care units and maternal mortality. Regional Teams for the Survey. European Journal of Obstetrics & Gynecology and Reproductive Biology 1996;65 (1):121-125
9. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, et al.The detection, investigation and management of hypertension in pregnancy: full consensus statement. Australian and New Zealand Journal of Obstetrics and Gynaecology 2000;40(2):139-155 (Pubitemid 30323584)
10. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertension in Pregnancy 2001;20(1):IX-XIV. (Pubitemid 32672922)
11. Churchill D, Duley L. Interventionist versus expectant care for severe pre-eclampsia before term. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD003106]
12. Churchill D, Beevers GD, Meher S, Rhodes C. Diuretics for preventing pre-eclampsia. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD004451.pub2]
13. de Swiet M. Medical disorders in obstetric practice. 4th Edition. Oxford: Blackwell Science, 2002.
14. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic reviews in health care: meta-analysis in context. London: BMJ Books, 2001:313-335
15. Douglas KA, Redman CW. Eclampsia in the United Kingdom. BMJ 1994;309(6966):1395-1400
16. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005;330 (7491):565. (Pubitemid 40380349)
17. Duley L. Maternalmortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. British Journal of Obstetrics and Gynaecology 1992;99(7):547-553
18. Duley L, Williams J, Henderson-Smart DJ. Plasma volume expansion for treatment of pre-eclampsia. Cochrane Database of Systematic Reviews 1999, Issue 4. [DOI: 10.1002/14651858.CD001805]
19. Duley L, Gülmezoglu AM. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database of Systematic Reviews 2000, Issue 3. [DOI: 10.1002/14651858.CD002960]
20. Duley L, Gülmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD000025]
21. Duley L, Henderson-Smart DJ. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD000127]
22. Duley L, Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD000128]
23. Duley L, Henderson-Smart D, Meher S. Altered dietary salt for preventing pre-eclampsia, and its complications. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD005548]
24. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD001449.pub2]
25. Duley L, Meher S, Abalos E. Management of pre-eclampsia. BMJ 2006;332(7539):463-468
26. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD004659.pub2] (Pubitemid 351805710)
27. Duley L, Matar HE, Almerie MQ, Hall D. Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD007388]
28. Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345(8963):1455-1463
29. Engelhard IM, van Rij M, Boullart I, Ekhart TH, Spaanderman ME, van den Hout MA, et al.Posttraumatic stress disorder after pre-eclampsia: an exploratory study. General Hospital Psychiatry 2002; 24(4):260-264 (Pubitemid 34718153)
30. Gülmezoglu AM, Hofmeyr GJ, Oosthuisen MM. Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial. British Journal of Obstetrics and Gynaecology 1997; 104(6):689-696 (Pubitemid 27278352)
31. Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart 1997;77(2):154-158
32. Hewitt BG, Newnham JP. A review of the obstetric andmedical complications leading to the delivery of infants of very low birthweight. Medical Journal of Australia 1988;149(5):234, 236, 238 passim.
33. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochranehandbook. org..
34. Hofmeyr GJ, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD001059.pub2]
35. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367(9516):1066-1074
36. Knight M. Eclampsia in the United Kingdom 2005. BJOG: an international journal of obstetrics and gynaecology 2007;114(9):1072-1078
37. Koopmans CM, Bijlenga D, Aarnoudse JG, van Beek E, Bekedam DJ, van den Berg PP, et al.Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial. BMC Pregnancy and Childbirth 2007;7:14. (Pubitemid 47386797)
38. Kramer MS, Seguin L, Lydon J, Goulet L. Socio-economic disparities in pregnancy outcome: why do the poor fare so poorly?. Paediatric and Perinatal Epidemiology 2000;14(3):194-210. (Pubitemid 30599067)
39. Kramer MS, Kakuma R. Energy and protein intake in pregnancy. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD000032]
40. Kröner C, Turnbull D, Wilkinson C. Antenatal day care units versus hospital admission for women with complicated pregnancy. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD001803]
41. Lewis G. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer - 2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH, 2007.
42. Magee L, Sadeghi S. Prevention and treatment of postpartum hypertension. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD004351.pub2]
43. Mahomed K, Bhutta Z, Middleton P. Zinc supplementation for improving pregnancy and infant outcome. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD000230.pub3] (Pubitemid 351805948)
44. Makrides M, Crowther CA. Magnesium supplementation in pregnancy. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD000937]
45. Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD003402.pub2]
46. Matchaba P, Moodley J. Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD002076.pub2]
47. Meads CA, Cnossen JS, Meher S, Juarez-Garcia A, ter Riet G, Duley L, et al.Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technology Assessment 2008;12(6):iii-iv, 1-270.
48. Meher S, Duley L, Prevention of Pre-eclampsia Cochrane Review authors. Interventions for preventing pre-eclampsia and its consequences: generic protocol. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD005301]
49. Meher S, Duley L. Exercise or other physical activity for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD005942]
50. Meher S, Duley L. Garlic for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD006065]
51. Meher S, Duley L. Progesterone for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD006175] (Pubitemid 46841297)
52. Meher S, Duley L. Rest during pregnancy for preventing pre-eclampsia and its complications in women with normal blood pressure. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD005939]
53. Meher S, Duley L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD006490] (Pubitemid 351805710)
54. Milne F, Redman C, Walker J, Baker P, Bradley J, Cooper C, et al.The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 2005;330 (7491):576-580
55. Anonymous. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. American Journal of Obstetrics and Gynecology 2000;183(1):S1-S22.
56. Anonymous. Antenatal care: routine care for the healthy pregnant woman. London: National Institute for Clinical Excellence, 2003.
57. Perel P, Roberts IG. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD000567.pub3] (Pubitemid 351805192)
58. The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration, 2008.
59. Roberts JM, Lain KY. Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002;23(5):359-372
60. Roberts CL, Algert CS, Morris JM, Ford JB, Henderson-Smart DJ. Hypertensive disorders in pregnancy: a population-based study. Medical Journal of Australia 2005;182(7):332-335 (Pubitemid 40514929)
61. Rosenberg K, Twaddle S. Screening and surveillance of pregnancy hypertension--an economic approach to the use of daycare. Baillieres Clinical Obstetrics and Gynaecology 1990;4(1):89-107. (Pubitemid 20232494)
62. Rumbold A, Duley L, Crowther CA, Haslam RR. Antioxidants for preventing pre-eclampsia. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD004227.pub3]
63. Shennan A, Waugh J. The measurement of blood pressure and proteinuria in pregnancy. In: Critchley H, MacLean A, Poston L, Walker J editor(s). Pre-eclampsia. London: RCOG Press, 2003:305-324
64. Steyn DW, Steyn P. Low-dose dopamine for women with severe pre-eclampsia. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD003515.pub2] (Pubitemid 351820506)
65. Villar J, Carroli G, Khan-Neelofur D, Piaggio G, Gülmezoglu M. Patterns of routine antenatal care for low-risk pregnancy. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD000934]
66. Walker MC, Ferguson SE, Allen VM. Heparin for pregnant women with acquired or inherited thrombophilias. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD003580]
67. World Health Organization. Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. American Journal of Obstetrics and Gynecology 1988;158(1):80-83
68. World Health Organization. The World Health Report 2005: Make every mother and child count. Geneva: World Health Organization, 2005.
69. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, et al.Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003;326(7394):845. (Pubitemid 36461414)
70. Zhang J, Wu TX, Liu GJ. Chinese herbal medicine for the treatment of pre-eclampsia. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD005126.pub2] * Indicates the major publication for the study